Fractionated Stereotactic Body Radiosurgery for Extracranial Tumors
- Determine the feasibility of fractionated stereotactic body radiosurgery in patients
with advanced extracranial tumors.
- Assess the toxicities of this treatment regimen in these patients.
- Determine tumor response and cause of death in these patients treated with this
OUTLINE: Patients receive fractionated stereotactic body radiosurgery over 30 minutes for
5-10 days for a total of 3 treatments.
Patients are followed every 3 months.
PROJECTED ACCRUAL: A total of 10-25 patients will be accrued within 2-3 years.
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Masking: Open Label, Primary Purpose: Treatment
Danny Y. Song, MD
Massey Cancer Center
United States: Federal Government
|Massey Cancer Center||Richmond, Virginia 23298-0037|